Bayesian modelling for COVID-19 seroprevalence studies

Por um escritor misterioso

Descrição

Bayesian modelling for COVID-19 seroprevalence studies
Estimates of the severity of coronavirus disease 2019: a model-based analysis - The Lancet Infectious Diseases
Bayesian modelling for COVID-19 seroprevalence studies
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
Bayesian modelling for COVID-19 seroprevalence studies
Update on SARS-CoV-2 seroprevalence: regional and worldwide - ScienceDirect
Bayesian modelling for COVID-19 seroprevalence studies
Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA
Bayesian modelling for COVID-19 seroprevalence studies
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet
Bayesian modelling for COVID-19 seroprevalence studies
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile
Bayesian modelling for COVID-19 seroprevalence studies
A simplified version of the Bayesian network for COVID-19 risk assessment
Bayesian modelling for COVID-19 seroprevalence studies
Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
Bayesian modelling for COVID-19 seroprevalence studies
Data-driven modeling of covid-21 - living matter lab
Bayesian modelling for COVID-19 seroprevalence studies
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study
Bayesian modelling for COVID-19 seroprevalence studies
Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
de por adulto (o preço varia de acordo com o tamanho do grupo)